I recently had the opportunity to chat with MedAngel’s founder, Amin Zayani. MedAngel is a device that helps people keep track of the temperature…
Category: Insulin
A faster acting mealtime insulin is now approved and available in Canada.
Novo Nordisk Canada Inc. announced that Fiasp (insulin aspart), a…
This week, Novo Nordisk and CVS Health announced a new program that will offer discounts on insulin, a life-sustaining drug for people with diabetes.…
Eleven people living with diabetes, with the support of the law firm Hagens Berman, have filed a class action lawsuit in Massachusetts against…
The first time I took Afrezza––an inhalable fast-acting insulin––in public, it was at Wildair, a small, hip restaurant in Manhattan. I inhaled…
Starting January 1, people who pay the highest out-of-pocket prices for insulin, such as those who pay full retail price at the pharmacy, may directly…
The maker of inhaled insulin Afrezza is betting that relaunching their product and making it a success depends less on diabetics being afraid of…
According to an article published on Seeking Alpha, Novo Nordisk has decided to make some significant changes in its drug development strategy…
New research says there are better ways to inject insulin with a syringe, as well as manage infusion sites, to get the most out of your insulin and improve diabetes care.
JDRF, partnered with Sanofi, the company that manufactures Lantus among other insulins, recently pledged up to $4.6 million to support research into four different efforts to design a glucose-responsive insulin.